Compare BODI & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BODI | COCH |
|---|---|---|
| Founded | 1998 | 1995 |
| Country | United States | United States |
| Employees | N/A | 47 |
| Industry | Industrial Machinery/Components | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8M | 52.5M |
| IPO Year | 2020 | 2021 |
| Metric | BODI | COCH |
|---|---|---|
| Price | $4.75 | $0.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $17.00 | $2.00 |
| AVG Volume (30 Days) | 23.4K | ★ 51.9K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.10 | 17.45 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $251,727,000.00 | $241,000.00 |
| Revenue This Year | N/A | $3.73 |
| Revenue Next Year | $12.09 | $24.00 |
| P/E Ratio | $10.02 | ★ N/A |
| Revenue Growth | N/A | ★ 7.11 |
| 52 Week Low | $4.05 | $0.36 |
| 52 Week High | $16.87 | $1.89 |
| Indicator | BODI | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 29.31 | 42.92 |
| Support Level | N/A | $0.67 |
| Resistance Level | $11.36 | $0.74 |
| Average True Range (ATR) | 0.25 | 0.03 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 23.47 | 11.11 |
The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.